Pulmonary hypertension, primary, 4
Also known as KCNK3 primary pulmonary hypertension, primary pulmonary hypertension caused by mutation in KCNK3, pulmonary hypertension, primary, type 4, PPH4.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Evidence coverage
How much of this condition's readable clinical evidence the confidence engine has incorporated, across its most-studied treatments. This measures coverage of the evidence base — not whether any treatment works.
Largest gap: no meaningful change (9, trial-readability).
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
KCNK3 primary pulmonary hypertension, primary pulmonary hypertension caused by mutation in KCNK3, pulmonary hypertension, primary, type 4, PPH4
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.